Knowles CH, Canestrari E, Jankowski RJ, Cardello K, Raval MJ. Safety and Efficacy of Iltamiocel Cellular Therapy for the Treatment of Fecal Incontinence. Results of a Phase 1/2 Study. Ann Surg. 2023 Dec 1;278(6):937-944.


Nativ-Zeltzer N, Kuhn MA, Evangelista L, Anderson JD, Nolta JA, Farwell DG, Canestrari E, Jankowski RJ, Belafsky PC. Autologous Muscle-Derived Cell Therapy for Swallowing Impairment in Patients Following Treatment for Head and Neck Cancer. Laryngoscope. 2022 Mar;132(3):523-527. doi: 10.1002/lary.29606.


Gilleran J, Diokno AC, Ward E, Sirls L, Hasenau D, Giordano J, Shea E, Bartolone SN, Lamb LE, Chancellor MB. Improved global response outcome after intradetrusor injection of adult muscle-derived cells for the treatment of underactive bladder. Int Urol Nephrol. 2021 Jul;53(7):1331-1338. doi: 10.1007/s11255-021-02847-1.


Jankowski RJ, Tu LM, Carlson C, et al. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence. Int Urol Nephrol. 2018;50(12):2153-2165. doi:10.1007/s11255-018-2005-8


Chancellor MB, Bartolone SN, DeVries EM, et al. New technology assessment and current and upcoming therapies for underactive bladder. Neurourol Urodyn. 2018;37(8):2932-2937. doi:10.1002/nau.23738


Peters KM, Dmochowski RR, Carr LK, et al. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol. 2014;192(2):469-476. doi:10.1016/j.juro.2014.02.047


Carr LK, Robert M, Kultgen PL, et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol. 2013;189(2):595-601. doi:10.1016/j.juro.2012.09.028


Carr LK, Steele D, Steele S, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(6):881-883. doi:10.1007/s00192-007-0553-z